Singulair Warning Upgraded
from Dr. Howard Smith OnCall Hosted by Howard G. Smith MD, AM
Vidcast: https://youtu.be/P8V4d3XQpQ4 The FDA has ordered an upgrade of the warnings for montelukast, branded as Singulair and sold as a generic product as well. This drug can trigger dangerous mind-altering side effects including suicidal thoughts and actions. This drug is used by children and adults for management of allergies and asthma. It is used for seasonal allergic rhinitis for those 2 years and older and for exercise-induced asthma for those 6 years and older. The FDA recommends that parents and patients using this drug be aware of the risks and speak with doctors about alternative medications. Those with pre-existing psychiatric illness should not use the drug. Please report any and all adverse effects while using montelukast Singuair to the FDA at 1-800-332-1088. https://www.fda.gov/safety/medical-product-safety-information/singulair-montelukast-and-all-montelukast-generics-strengthened-boxed-warning-due-restricting-use #warning #suicide #depression #singulair #montelukast #allergy #asthma
Embed this episode
No transcript yet.